| Gennex Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 531739 |
NSE Symbol : - |
P/E(TTM) : 13.26 |
|
ISIN Demat : INE509C01026 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.68 |
|
Book Value(₹) : 8.98 |
Market Cap(₹Cr) : 219.14 |
Face Value(₹) : 1.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 34.68 | 36.71 | 28.18 | 29.33 | 25.64 | 23.28 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 34.68 | 36.71 | 28.18 | 29.33 | 25.64 | 23.28 |
| Other Operating Income | 0.00 | 0.00 | 2.54 | 2.04 | 0.00 | 0.00 |
| Other Income | 2.00 | 1.30 | 0.00 | 0.00 | 2.26 | 2.87 |
| Total Income | 36.67 | 38.01 | 30.71 | 31.37 | 27.90 | 26.15 |
| Total Expenditure | 31.72 | 33.83 | 24.86 | 25.37 | 22.26 | 23.21 |
| PBIDT | 4.95 | 4.18 | 5.85 | 5.99 | 5.64 | 2.94 |
| Interest | 0.51 | 0.63 | 0.69 | 0.55 | 0.59 | 0.23 |
| PBDT | 4.44 | 3.55 | 5.16 | 5.44 | 5.05 | 2.71 |
| Depreciation | 0.24 | 0.35 | 0.21 | 0.21 | 0.20 | 0.53 |
| Tax | 0.25 | 0.00 | 0.50 | 0.70 | 0.70 | 0.62 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.21 | 0.00 | 0.00 | 0.00 | 0.05 |
| Reported Profit After Tax | 3.96 | 2.99 | 4.45 | 4.53 | 4.15 | 1.50 |
| Extra-ordinary Items | 0.00 | -0.28 | -0.27 | 0.00 | 0.00 | -0.10 |
| Adjusted Profit After Extra-ordinary item | 3.96 | 3.27 | 4.72 | 4.53 | 4.15 | 1.60 |
| EPS (Unit Curr.) | 0.16 | 0.13 | 0.18 | 0.19 | 0.18 | 0.07 |
| EPS (Adj) (Unit Curr.) | 0.16 | 0.13 | 0.18 | 0.19 | 0.18 | 0.07 |
| Calculated EPS (Unit Curr.) | 0.16 | 0.12 | 0.18 | 0.19 | 0.18 | 0.07 |
| Calculated EPS (Adj) (Unit Curr.) | 0.16 | 0.12 | 0.18 | 0.19 | 0.18 | 0.07 |
| Calculated EPS (Ann.) (Unit Curr.) | 0.65 | 0.49 | 0.73 | 0.75 | 0.72 | 0.26 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 0.65 | 0.49 | 0.73 | 0.75 | 0.72 | 0.26 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 24.29 | 24.29 | 24.29 | 24.29 | 23.14 | 22.74 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 14.27 | 11.39 | 20.76 | 20.42 | 22.00 | 12.63 |
| PBDTM(%) | 12.80 | 9.67 | 18.31 | 18.55 | 19.70 | 11.64 |
| PATM(%) | 11.42 | 8.14 | 15.79 | 15.44 | 16.19 | 6.44 |
